Find the right fit for you - faster
Get tailored insights about working at Zealand Pharma in one quick step.
Zealand Pharma Snapshot
We discover and develop peptide therapeutics with a focus on specialty gastrointestinal and metabolic diseases.
Zealand Pharma A/S (is a biotechnology company focused on the discovery, development, and commercialization of peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market and three candidates are in late-stage development. In addition, license collaborations with Boehringer Ingelheim and AstraZeneca create opportunities for more patients to potentially benefit from Zealand-invented peptide investigational agents currently in development.
At Zealand, our goal is to offer new and reliable peptide-based treatment options that can ease the burden on patients, their caregivers, and the health care system. We pride ourselves on our ability to work together as one team, and foster a strong company culture founded on collaboration, innovation, empowerment, and trust. Zealand is headquartered Copenhagen, Denmark, and also has presence throughout the U.S. that includes key locations in Boston and Marlborough, Massachusetts.
At Zealand, our goal is to offer new and reliable peptide-based treatment options that can ease the burden on patients, their caregivers, and the health care system. We pride ourselves on our ability to work together as one team, and foster a strong company culture founded on collaboration, innovation, empowerment, and trust. Zealand is headquartered Copenhagen, Denmark, and also has presence throughout the U.S. that includes key locations in Boston and Marlborough, Massachusetts.
